{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-088220","form_type":"8-K","ticker":"CLDX","cik":"0000744218","company_name":"Celldex Therapeutics, Inc.","filed_at":"2021-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.677498+00:00","generated_at":"2026-06-30T08:16:29.707874+00:00","sec_items":["5.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Celldex enters amended employment agreements with 10 executives, new salaries and bonus targets","bullets":["CEO Marucci base salary $680,908 (60% bonus); CFO Martin $412,820 (40% bonus).","Initial term through Dec 31, 2021, auto-renew yearly unless 90-day notice.","Severance: 200% base salary lump sum on termination w/o cause or for good reason, plus 18 months COBRA.","25% of unvested equity vests immediately on such termination.","Agreements standardize language; prior agreements restated effective July 1, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-088220","json":"https://secwatch.observer/filing/0001104659-21-088220.json","markdown":"https://secwatch.observer/filing/0001104659-21-088220.md","text":"https://secwatch.observer/filing/0001104659-21-088220.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/744218/000110465921088220/0001104659-21-088220-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/744218/000110465921088220/tm2120284d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T08:16:29.707874+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}